| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |